Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC6A12 | P48065 | 1/20 | 0.36 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.33 |
| ▸ | GABRP | O00591 | 2/20 | 0.33 |
| ▸ | GABRD | O14764 | 2/20 | 0.33 |
| ▸ | GABRA1 | P14867 | 2/20 | 0.33 |
| ▸ | GABRB1 | P18505 | 2/20 | 0.33 |
| ▸ | GABRG2 | P18507 | 2/20 | 0.33 |
| ▸ | GABRB3 | P28472 | 2/20 | 0.33 |
| ▸ | GABRA5 | P31644 | 2/20 | 0.33 |
| ▸ | GABRA3 | P34903 | 2/20 | 0.33 |
| ▸ | GABRA2 | P47869 | 2/20 | 0.33 |
| ▸ | GABRB2 | P47870 | 2/20 | 0.33 |
| ▸ | GABRA4 | P48169 | 2/20 | 0.33 |
| ▸ | GABRE | P78334 | 2/20 | 0.33 |
| ▸ | GABRA6 | Q16445 | 2/20 | 0.33 |
| ▸ | GABRG1 | Q8N1C3 | 2/20 | 0.33 |
| ▸ | GABRG3 | Q99928 | 2/20 | 0.33 |
| ▸ | GABRQ | Q9UN88 | 2/20 | 0.33 |
| ▸ | HTT | P42858 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5158128 | 0.83 | SLC6A12 (0.37) | SLC6A12L3MBTL1ALDH1A1GABRPGABRD | |
| SCHEMBL29922180 | 0.82 | SLC6A12 (0.36) | SLC6A12L3MBTL1ALDH1A1GABRPGABRD | |
| SCHEMBL8801541 | 0.78 | ALDH1A1 (0.38) | L3MBTL1ALDH1A1HTTKLKB1KLK1 | |
| SCHEMBL8548280 | 0.77 | SLC6A12 (0.34) | SLC6A12L3MBTL1ALDH1A1GABRPGABRD | |
| SCHEMBL8547431 | 0.77 | HSP90AB1 (0.43) | SLC6A12L3MBTL1ALDH1A1GABRPGABRD | |
| SCHEMBL9144675 | 0.75 | SLC6A12 (0.37) | SLC6A12ALDH1A1GABRPGABRDGABRA1 | |
| SCHEMBL5796439 | 0.75 | KEAP1 (0.35) | ALDH1A1HTTADORA1KDM4E | |
| SCHEMBL3702546 | 0.74 | SMN1; SMN2 (0.40) | SLC6A12ALDH1A1GABRPGABRDGABRA1 | |
| SCHEMBL30436565 | 0.74 | SMN1; SMN2 (0.40) | SLC6A12ALDH1A1GABRPGABRDGABRA1 | |
| SCHEMBL29550931 | 0.72 | TSHR (0.52) | ALDH1A1KMT2ATSHRKDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1675858-A2 | 5-ARYL-PYRAZOLO [4,3-D] PYRIMIDINES, PYRIDINES, AND PYRAZINES AND RELATED COMPOUNDS | NEUROGEN CORPORATION (US) | 2006-07-05 | — | — | EP | disclosed |
| US-20050070542-A1 | 5-Aryl-pyrazolo[4,3-d]pyrimidines, pyridines, and pyrazines and related compounds | NEUROGEN CORPORATION | 2005-03-31 | — | — | US | disclosed |
| WO-2005028480-A2 | 5-ARYL-PYRAZOLO[4,3-D]PYRIMIDINES, PYRIDINES, AND PYRAZINES AND RELATED COMPOUNDS | NEUROGEN CORPORATION (US) | 2005-03-31 | — | — | WO | disclosed |
| US-6844398-B2 | Ethylenic copolymer, composition containing said copolymer, and ethylenic copolymer film | IDEMITSU KOSAN CO., LTD. (JP) | 2005-01-18 | — | — | US | disclosed |
| US-20020188087-A1 | Ethylenic copolymer, composition containing said copolymer, and ethylenic copolymer film | IDEMITSU KOSAN CO., LTD. (JP) | 2002-12-12 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050070542-A1 | 5-Aryl-pyrazolo[4,3-d]pyrimidines, pyridines, and pyrazines and related compounds | CRHR1, HTR5A, HTR1D | SLC6A12 4205/4885L3MBTL1 4407/4885ALDH1A1 1664/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.